References
- Cameron JS. Membranous nephropathy and its treatment. Nephrol Dial Transplant. 1992;7(Suppl 1):72–79
- Ponticelli C, Zucchelli P, Passerini P, et al. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med. 1989;320:8–13
- Ponticelli C, Zucchelli P, Passerini P, et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int. 1995;48:1600–1604
- Schieppati A, Mosconi L, Perna A, et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med. 1993;329:85–89
- Jha V, Ganguli A, Saha TK, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol. 2007;18:1899–1904
- Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol. 2003;23:324–332
- Hogan SL, Muller KE, Jennette CJ, Falk RJ. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kid Dis. 1995;25(6):862–875
- International Study of Kidney Disease in Children. Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int. 1978;13:159–165
- Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC. Toronto Glomerulonephritis Registry Group: Idiopathic membranous nephropathy: Definition and relevance of a partial remission. Kidney Int. 2004;66:1199–1205
- Passerini P, Ponticelli C. Membranous nephropathy. In: Ponticelli C, Glassock RJ, eds. Treatment of Primary Glomerulonephritis (Oxford Clinical Nephrology Series). Oxford: Oxford University Press; 2009:261–313
- Cattran DC. Outcomes research in glomerulonephritis. Semin Nephrol. 2003;23:340–354
- du Buf-Vereijken PW, Branten AJ, Wetzels JF. Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy. Am J Kidney Dis. 2005;46:1012–1029
- Branten AJW, Vervoort G, Wetzels JF. Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant. 2005;20:707–711
- KDIGO Clinical Practice Guideline for Glomerulonephritis. Idiopathic membranous nephropathy. Kid Int Suppl. 2012;2:186–197
- Perna A, Schieppati A, Zamora J, Giuliano GA, Braun N, Remuzzi G. Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review. Am J Kidney Dis. 2004;44:385–401
- Donadio JV Jr, Holley KE, Anderson CF, Taylor WF. Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int. 1974;6:431–439
- Murphy BF, McDonald I, Fairley KF, Kincaid-Smith PS. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis. Clin Nephrol. 1992;37:229–234
- Braun N, Erley CM, Benda N, Zauner I, Kanis R, Grupp C. Therapy of membranous glomerulonephritis with nephrotic syndrome: 5 Years follow-up of a prospective randomized multi-center study. J Am Soc Nephrol. 1995;6:413A (abstr)